Cataract News and Research

Latest Cataract News and Research

Resveratrol shown to reduce age related health problems

Researchers in the U.S. have found that a compound found in grapes and red wine can significantly reduce age related health problems.

7 Jul 2008

Resveratrol mimics the beneficial effects of eating fewer calories

Large doses of a red wine ingredient can ward off many of the vagaries of aging in mice who begin taking it at midlife, according to a new report published online on July 3rd in Cell Metabolism, a Cell Press publication.

3 Jul 2008

Resveratrol improves health, but not longevity in aging mice

Scientists have found that the compound resveratrol slows age-related deterioration and functional decline of mice on a standard diet, but does not increase longevity when started at middle age.

3 Jul 2008

Tumor suppressor genes speed up and slow down aging in engineered mouse

Mayo Clinic researchers have developed an animal model that can test the function of two prominent tumor suppressor genes, p16 and p19, in the aging process. Scientists knew that both these genes were expressed at increased levels as humans and mice age, but their role in the aging process was not clear. Findings by the Mayo team show that p16 provides gas to accelerate cellular aging, while p19 stops that process.

1 Jun 2008

New findings on vitamin E and cataracts in women

A new analysis of the Women's Health Study (WHS) found that women who took Vitamin E supplements had rates of cataract development comparable to women who did not take such supplements.

1 May 2008

Children more vulnerable to harmful effects of lead at age 6 than as toddlers

Contrary to prevailing assumptions, children are more vulnerable to the harmful effects of lead exposure at the age of 6 than they are in early childhood, according to a Cincinnati Children's Hospital Medical Center study to be presented May 4 at the annual meeting of the Pediatric Academic Societies in Honolulu.

30 Apr 2008

Laser eye surgery comes under close scrutiny

More and more people are having laser vision corrective surgery (LASIK surgery) in the hope that their vision will be restored to such an extent that glasses will no longer be needed.

28 Apr 2008

New clues to cataract formation

It is the No. 1 line-item cost of Medicare reimbursement and affects more than 20 million people in the United States. Cataracts, which can have devastating effects on the eye, affect 42 percent of the population between the ages of 70 and 80, and 68 percent of the population over the age of 80, according to the National Eye Institute.

17 Apr 2008

Very early photoscreening yields better visual outcomes in amblyopia treatment

Children who screen positive for amblyopia, reduced vision in one eye, before age 2 appear to have better visual outcomes than those whose vision problems are detected during screenings between ages 2 and 4, according to a report in the April issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

15 Apr 2008

Easter eye warning as occy straps lash out

Easter-period travellers are being warned to take care with octopus straps that hospitalise 540 people each year with severe eye injuries.

21 Mar 2008

LASIK patients overwhelmingly happy with procedure results

Worldwide, an average 95.4 percent of LASIK patients are satisfied with their new vision, according to the first review of the world body of scientific literature, the American Society of Cataract and Refractive Surgery (ASCRS) announced today.

10 Mar 2008

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.

1 Mar 2008

Are cataract rates on the decline?

Should glaucoma patients seeking alternative therapies trust what they find online? Are seatbelts still important to protect eyes in auto accidents, now that most cars have airbags? What's the connection between hearing loss and one form of glaucoma? These are among the topics explored in the March 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.

28 Feb 2008

Role gound for glaucoma gene and a signaling pathway

Researchers have found that a gene and a related signaling pathway play a role in the development of glaucoma, which is a common cause of visual impairment and blindness worldwide.

18 Feb 2008

Discovery of new cataract gene

The international team of researchers was able to identify the location and defect in the coding region of the gene through analysis of genetic material (DNA) from members of a large Swiss family, the majority of whom suffered from autosomal dominant juvenile cataract.

17 Feb 2008

FDA approves only once-daily inhaled corticosteroid for children

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved ASMANEX TWISTHALER 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a preventive therapy in patients 4 to 11 years of age.

4 Feb 2008

Special report on the aging eye

Cataract surgery involves removing a clouded natural lens from inside the eye and replacing it with a plastic one.

21 Jan 2008

Diets high in lutein, zeaxanthin and vitamin E lower risk for cataracts

Women who have higher dietary intake of lutein and zeaxanthin—compounds found in yellow or dark, leafy vegetables—as well as more vitamin E from food and supplements appear to have a lower risk for developing cataracts, according to a report in the January issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

15 Jan 2008

Variability in health care treatment costs amongst 9 EU countries

With ‘health tourism' rising across the European Union, consumers, insurers and Governments are increasingly interested in the relative cost of common procedures in different countries.

9 Jan 2008

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

AstraZeneca has announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.

3 Jan 2008